Clinical trial
Validation of the Assay of Circulating Antibodies Against Glomerular Neo-autoantigens as a Surrogate Biomarker of the Development of Lupus Nephritis
NCT02403115 is registered in ClinicalTrials.gov with Istituto Giannina Gaslini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of the Assay of Circulating Antibodies Against Glomerular Neo-autoantigens as a Surrogate Biomarker of the Development of Lupus Nephritis
- Lead sponsor
- Istituto Giannina Gaslini
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- November 30, 2022
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus